Recent Finacing
Recent Raise
NeoPhore discovers and develops small-molecule inhibitors of the DNA mismatch repair pathway to induce neoantigen formation, increase tumor immunogenicity, and advance immuno-oncology candidates through preclinical and IND-enabling studies.
